E-Z-EM launches new blood analyser:
This article was originally published in Clinica
E-Z-EM, of Lake Success, New York, has formally launched its EZ CHEM blood analyser, a convenient point-of-care blood assay device for use in patients due to undergo certain imaging procedures. The device assesses kidney function by analysing a finger prick sample of blood for levels of creatinine, an indicator of a patient's renal function. Renal function of some patients, usually older patients or those with diabetes or kidney impairment, is a measure of their ability to safely receive IV contrast imaging agents prior to CT and MR imaging procedures. Currently, blood tests must be sent to a lab before the patient can undergo these. Waltham, Massachusetts-based Nova Biomedical, E-Z-EM's development partner for the analyser, gained US 510(k) clearance for the base technology, called StatSensor, in May.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.